Dunad Therapeutics

Description: Dunad Therapeutics develops next-gen protein degradation therapies using tunable small molecules for selective, drug-like, orally bioavailable degraders.

Country: UK

Based in: London

Founded: 2020

Funding Stage: Pre-Seed

Tags: ['Biotechnology', 'Life Science', 'Medical', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.